Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization
Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline
Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline
What's Your Reaction?
